In the present study we investigated whether treatment with the GLP-2 analogue teduglutide improves liver injury in the Mdr2/Abcb4-/- mouse model of sclerosing cholangitis possibly via activation of NR4a1/Nur77 in HSCs. This evidence concerns the gene GCG and sclerosing cholangitis.